Healthcare Platforms and Monitoring Technology Attract Fresh Commercial Attention

Healthcare Platforms and Monitoring Technology Attract Fresh Commercial Attention — (ASX:PHX), (ASX:TAL), (ASX:SMN)

Aditi Sarkar

11 November 2026 04:32 PM AEDT

Healthcare Platforms and Monitoring Technology Attract Fresh Commercial Attention — (ASX:PHX), (ASX:TAL), (ASX:SMN)

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Pharmx released its FY26 results and accompanying investor presentation on 27 August 2026.
Talius announced a three-year agreement valued at AUD 1.65 mn with Adventist Retirement Plus in August 2026.
Structural Monitoring Systems operates avionics, contract Manufacturing and structural monitoring activities through Canadian Subsidiary AEM.
Pharmx Technologies Limited recorded a 2.94% move on 11 November 2026, the largest quoted percentage gain among the trio.

Technology used to manage a pharmacy network, monitor aged-care residents or assess aircraft structures serves very different markets—but each depends on trusted operational data. Pharmx Technologies Limited (ASX:PHX), Talius Group Limited (ASX:TAL) and Structural Monitoring Systems Plc (ASX:SMN) are approaching that challenge from different directions. Their 11 November 2026 share-price movements offer a market snapshot, but the more revealing story lies in the contracts, products and operating figures behind each business.

Pharmx: A Pharmacy Technology Base

Pharmx released its FY26 results and accompanying investor presentation on 27 August 2026. Earlier in 2026, the company described a strategic alliance with Sigma Healthcare as part of its market development.

On 11 November 2026, Pharmx Technologies Limited shares rose 2.94% to AUD 0.07; the indicated Market Capitalisation was AUD 46.8 mn.

Talius: Remote Monitoring Wins a Contract

In August 2026, Talius announced a three-year AUD 1.65 mn agreement with Adventist Retirement Plus. The contract followed a separate three-year arrangement with Longridge Aged Care announced in July.

Both agreements concern care-sector customers and extend the company’s exposure to longer-term technology and service delivery. Contract value and duration are important, but Revenue recognition depends on the underlying service terms and implementation schedule.

The 11 November 2026 price listing showed AUD 0.055 for Talius Group Limited, with a market capitalisation of AUD 18.96 mn; zero quoted movement does not necessarily confirm active trading.

Structural Monitoring: Aviation Technology Has Its Own Cycle

Structural Monitoring Systems operates through its Canadian subsidiary Anodyne Electronics Manufacturing, known as AEM. The group identifies three Business segments: branded avionics, contract manufacturing and Comparative Vacuum Monitoring sensor systems.

Those operations have different commercial pathways. Avionics supplies specialist equipment, contract manufacturing serves selected customers, and CVM addresses the inspection of aircraft structures.

The 11 November 2026 price listing showed AUD 0.32 for Structural Monitoring Systems Plc, with a market capitalisation of AUD 50.28 mn; zero quoted movement does not necessarily confirm active trading.

Where Monitoring Meets Service Delivery

Customer contracts and delivery arrangements matter more than grouping these businesses under one label. Their reported milestones should be viewed against their specific industries.

What Comes Next

Next, watch for results that relate directly to these reported projects and business models. For Pharmx Technologies Limited, Talius Group Limited and Structural Monitoring Systems Plc, the relevant evidence will come from separately reported financial performance, contract delivery and customer uptake—not from assuming that one company’s milestone applies to the others.

FAQs

Q: Which three ASX stocks are discussed?

A: Pharmx Technologies Limited (ASX:PHX), Talius Group Limited (ASX:TAL) and Structural Monitoring Systems Plc (ASX:SMN).

Q: Which stock gained most on 11 November 2026?

A: Pharmx Technologies Limited recorded the largest quoted daily percentage rise among the three, at 2.94%.

Q: What should readers follow next?

A: Company announcements covering customer adoption, delivery milestones and financial performance relevant to each business.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.